A new observational study sponsored by the National Cancer Institute aims to evaluate treatment responses in patients with advanced central nervous system tumors, including various types of gliomas. The study is currently not yet recruiting participants.
Conditions: Recurrent CNS Tumors; Brain Cancer; Gliomas; IDH-wildtype Gliomas; IDH-mutant Gliomas; Rare CNS Tumor Interventions: Other: Tumor sample collection Sponsors: National Cancer Institute (NCI) Not yet recruiting
Original title: “Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors”